4.6 Article

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Silencing of PRDM5 increases cell proliferation and inhibits cell apoptosis in glioma

Xiaolin Wang et al.

Summary: The study showed that downregulation of PRDM5 promotes cell proliferation and reduces apoptosis in glioma cells, leading to poor prognosis in patients. These findings suggest that PRDM5 may be a potential therapeutic target for glioma.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Immunology

Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma

Adi Kartolo et al.

Summary: Serum eosinophilia can serve as an indicator for evaluating the efficacy of immunotherapy, especially in patients with advanced melanoma. The study suggests that eosinophilia during IO and its late timing may be associated with better immunotherapy efficacy.

IMMUNOTHERAPY (2021)

Article Medicine, Research & Experimental

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy

Miren Zuazo et al.

EMBO MOLECULAR MEDICINE (2019)

Article Oncology

Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function

Verena Deutschmeyer et al.

CLINICAL EPIGENETICS (2019)

Article Biochemistry & Molecular Biology

Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30

Mohammad Hossein Izadpanah et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2017)

Article Oncology

Cancer Statistics in China, 2015

Wanqing Chen et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Article Multidisciplinary Sciences

Zinc finger protein Loz1 is required for zinc-responsive regulation of gene expression in fission yeast

Mark E. Corkins et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Gastroenterology & Hepatology

Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric Washes

Yoshiyuki Watanabe et al.

GASTROENTEROLOGY (2009)

Article Biochemistry & Molecular Biology

Epigenetic regulation of protein-coding and MicroRNA genes by the gfi 1-interacting tumor suppressor PRDM5

Zhijun Duan et al.

MOLECULAR AND CELLULAR BIOLOGY (2007)

Article Multidisciplinary Sciences

Cyclin-dependent kinases regulate the antiproliferative function of Smads

I Matsuura et al.

NATURE (2004)

Article Biochemistry & Molecular Biology

PRDM5 is silenced in human cancers and has growth suppressive activities

QD Deng et al.

ONCOGENE (2004)

Review Biochemistry & Molecular Biology

SET domains and histone methylation

B Xiao et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2003)